New cancer treatments are developed through a rigorous process that begins with basic research, followed by preclinical studies and clinical trials. This process can take many years and involves several phases of testing to ensure that treatments are safe and effective. Researchers also rely on biomarkers to identify which patients are most likely to benefit from specific treatments.
